Adjunctive therapy with brexpiprazole improves treatment resistant complex post traumatic stress disorder in domestic family violence victims

Abstract

Objective:

Domestic family violence (FV) is a serious problem with serious impacts on mental health of victims. One such impact is post-traumatic stress disorder (PTSD), and it can be resistant to treatment (treatment-resistant or TR). This article offers novel treatment.

Methods:

Two treatment resistant case studies are described where adjunctive treatment with brexpiprazole was commenced. Possible theoretical considerations are presented to explain improvement.

Results:

Adjunctive treatment with brexpiprazole was associated with significant improvement in FV subjective and objective measures, with enhanced response to trauma therapy.

Conclusion:

Brexpiprazole improved complex post traumatic stress disorder in FV victims and needs further evaluation.

Keywords

Family violence victims TR-PTSD treatment resistance brexpiprazole

Get full access to this article

View all access options for this article.

References

World Health Organization (WHO), London School of Hygiene and Tropical Medicine. Preventing intimate partner and sexual violence against women and taking actions and generating evidence. Geneva (CH): WHO, 2010.

Australian Bureau of Statistics. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4510.0~2017~Main%20Features~Victims%20of%20Family%20and%20Domestic%20Violence%20Related%20Offences~6 (2018, accessed 5 June 2019).

Trevillion

Oram

Feder

, et al Experiences of domestic violence and mental disorders: a systematic review and meta-analysis. PLoS One 2012; 7: e51740.

O’Connor

Ibrahim

. Suicidality and family violence in Australian immigrant women presenting to out-patient mental health settings. Australas Psychiatry 2018; 26: 224–225.

Rees

Silove

Chey

, et al Lifetime prevalence of gender-based violence in women and the relationship with mental disorders and psychosocial function. JAMA 2011; 306: 513–521.

White Ribbon Australia. Domestic violence statistics. https://www.whiteribbon.org.au/understand-domestic-violence/facts-violence-women/domestic-violence-statistics/ (accessed 4 July 2019).

American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author, 2013.

Dunlop

Kaye

Youngner

, et al Assessing treatment-resistant posttraumatic stress disorder: the emory treatment resistance interview for PTSD (E-TRIP). Behav Sci (Basel) 2014; 4: 511–527.

Detweiler

Pagadala

Candelario

, et al Treatment of post-traumatic stress disorder nightmares at a veterans affairs medical center. J Clin Med 2016; 5: 117.

10.

Khazaie

Ghadami

Masoudi

. Sleep disturbances in veterans with chronic war-induced PTSD. J Inj Violence Res 2016; 8: 99–107.

11.

Hope

Castle

Keks

. Brexpiprazole: a new leaf on the partial dopamine agonist branch. Australas Psychiatry 2018; 26: 92–94.

12.

Otsuka Pharmaceutical Co., Ltd. Otsuka and Lundbeck report positive phase II data for the combination treatment of brexpiprazole and sertraline for the treatment of Post-Traumatic Stress Disorder (PTSD). 30 November 2018.

13.

Product information AusPAR Rexulti Brexpiprazole Lundbeck Australia Pty Ltd. https://www.tga.gov.au/sites/default/files/auspar-brexpiprazole-180924-pi.pdf (accessed 6 December 2019).

14.

Cohen

Zohar

Kaplan

, et al Adjunctive treatment with brexpiprazole and escitalopram reduces behavioural stress responses and increase hypothalamic NPY immunoreactivity in a rat model of PTSD-like symptoms. European Neuropsychopharmacol 2018; 28: 63–74.

15.

Hamner

Diamond

. Elevated plasma dopamine in posttraumatic stress disorder: a preliminary report. Biol Psychiatry 1993; 33: 304–306.

16.

Kapur

. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003; 160: 13–23.

17.

World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics Eleventh Revision. https://icd.who.int/icd11refguide/en/index.html (2019, accessed 6 December 2019).